Colorado’s Accelerated TMS Leader
An image of the TMS Center of Colorado logo
FREE PHONE CONSULTATION

TMS Treatment Outcomes

2024-current (8/26)

  • Patients treated: 187
  • Average PHQ-9 reduction (Standard): ~10 points
  • Average BDI-II reduction (standard): ~20 points
  • Average PHQ-9 reduction (accelerated): ~9 points
  • Average BDI-II reduction (accelerated): ~19 points
  • Response rate (standard): 83%
  • Remission rate (Standard): 40%
  • Response rate (accelerated): 76%
  • Remission Rate (accelerated): 47%
  • Average sessions to response (Standard): about session 25 (5 weeks in)
  • Completion rate: 95.5%
  • Patient satisfaction: 94.41% of patients are highly satisfied with services provided. Specifically, patients mention exceptional provider and staff care, professionalism, and comfortable atmosphere

TMS MDD Response Rate according to Age (Standard)

TMS MDD Response Rate according to Age (Accelerated)

*response rate is a reduction of 50% or greater in depression rating scales and remission is scores that have returned to a normal range in depression rating scales

TMS MDD Response Rates according to Age (standard and accelerated)

[Source: Adolescent TMS response] [Source: TMS efficacy w/ age] [Source: Meta Analysis- adults] [Source: Late-age TMS success]

Accelerated Protocol: Depressive Symptom Reduction

Assessments were taken before the evaluation, at the first session, about halfway through the course (25 sessions), and at the final treatment (50 sessions). Rating scales: BDI-II measures severity of depressive symptoms, GAD-7 measures presence and severity of anxiety, and PHQ-9 measures the presence and severity of depression. BDI-II scores reduced by about 60%

Standard Protocol: Depressive Symptom Reduction

Shows symptom improvement during the Standard 9 week treatment course. Assessments were taken before the evaluation, at the first session, weekly through the treatment course (about 9 weeks), at the final treatment (36 sessions), and two weeks post treatment. Rating scales: BDI-II measures severity of depressive symptoms, GAD-7 measures presence and severity of anxiety, and PHQ-9 measures the presence and severity of depression. BDI-II scores reduced by 70%.

Skip to content